首页> 美国卫生研究院文献>PLoS Clinical Trials >Value of TP53 Status for Predicting Response to Neoadjuvant Chemotherapy in Breast Cancer: A Meta-Analysis

【2h】

Value of TP53 Status for Predicting Response to Neoadjuvant Chemotherapy in Breast Cancer: A Meta-Analysis

机译：TP53状态在预测乳腺癌新辅助化疗反应中的价值：一项荟萃分析

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

BackgroundNumerous studies have yielded inconclusive results regarding the relationship between tumor suppressor protein TP53 overexpression and/or TP53 gene mutations and the response to neoadjuvant chemotherapy in patients with breast cancer. The purpose of the current study was therefore to evaluate the relationship between TP53 status and response to chemotherapy in breast cancer.

机译：背景：关于乳腺癌患者中肿瘤抑制蛋白TP53过表达和/或TP53基因突变与对新辅助化疗的反应之间的关系，许多研究尚未得出结论。因此，本研究的目的是评估TP53状况与乳腺癌对化学疗法的反应之间的关系。

著录项

期刊名称 PLoS Clinical Trials
作者
Min-Bin Chen; Ya-Qun Zhu; Jun-Ying Xu; Li-Qiang Wang; Chao-Ying Liu; Zhang-Yi Ji; Pei-Hua Lu;
展开▼
作者单位

展开▼
年(卷),期 2009(7),6
年度 2009
页码 e39655
总页数 6
原文格式 PDF
正文语种
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Axillary lymph node status, adjusted for pathologic complete response in breast and axilla after neoadjuvant chemotherapy, predicts differential disease-free survival in breast cancer [J] . C.Y. Ren, F.P. Xu, G.C. Zhang, Current oncology . 2013,第3期

机译：根据新辅助化疗后乳腺癌和腋窝的病理完全反应调整后的腋窝淋巴结状态，可预测乳腺癌的无病生存差异
2. The accuracy of F-18-FDG PET/CT in predicting the pathological response to neoadjuvant chemotherapy in patients with breast cancer: a meta-analysis and systematic review [J] . Tian Fangfang, Shen Guohua, Deng Yunfu, European radiology . 2017,第11期

机译：F-18-FDG PET / CT的准确性预测乳腺癌患者对Neoadjuvant化疗的病理反应：Meta分析和系统评论
3. Meta-analysis confirms achieving pathological complete response after neoadjuvant chemotherapy predicts favourable prognosis for breast cancer patients. [J] . Kong X, Moran MS, Zhang N, European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR) . 2011,第14期

机译：荟萃分析证实，在新辅助化疗预示乳腺癌患者预后良好后，将达到病理完全缓解。
4. Radiomics for predicting response to neoadjuvant chemotherapy treatment in breast cancer [C] . Simona Rabinovici-Cohen, Tal Tlusty, Ami Abutbul, Conference on Imaging Informatics for Healthcare, Research, and Applications . 2020

机译：用于预测对乳腺癌新辅助化疗治疗的反应的辐射瘤
5. Using Preoperative Mri-guided Biopsies to Predict Pathologic Complete Response after Neoadjuvant Chemotherapy in Breast Cancer [D] . Kim, Jiyoon. 2019

机译：在乳腺癌新辅助化疗后使用术前Mri引导的活检来预测病理完全缓解
6. Axillary lymph node status adjusted for pathologic complete response in breast and axilla after neoadjuvant chemotherapy predicts differential disease-free survival in breast cancer [O] . G.C. Zhang, Y.F. Zhang, F.P. Xu, 2013

机译：根据新辅助化疗后乳腺癌和腋窝的病理完全反应调整的腋窝淋巴结状态预测乳腺癌的无病生存差异
7. Value of TP53 Status for Predicting Response to Neoadjuvant Chemotherapy in Breast Cancer: A Meta-Analysis [O] . Chen, Min-Bin, Zhu, Ya-Qun, Xu, Jun-Ying, 2012

机译：TP53状态在预测乳腺癌新辅助化疗反应中的价值：一项荟萃分析

Value of TP53 Status for Predicting Response to Neoadjuvant Chemotherapy in Breast Cancer: A Meta-Analysis

摘要

著录项

相似文献

相关主题

期刊订阅